News tagged with adjuvant chemotherapy

70-gene signature not cost-effective in breast cancer

(HealthDay)—For patients with node-negative breast cancer (NNBC), the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making, according to a study published ...

Oct 18, 2014
popularity 3 / 5 (2) | comments 0

Study links age, insurance, but not race, to chemo rates

(HealthDay) -- For women with breast cancer, disease characteristics correlate significantly with chemotherapy receipt, with no indication of racial barriers to treatment, according to a study published online ...

Aug 10, 2012
popularity not rated yet | comments 0